Skip to main content
Start Project

Free field guide · PDF

FDA eSTAR: Electronic Submissions2026 Field Guide

The mandatory templates, the completeness checks, and the PMA expansion — with the submission practice you need.

Current template
v7.1
Mandatory since
2023 / 2025
PMA draft guidance
18 Sep 2026

Sourced from FDA and verified 2026 publications.

Download the free guide

Enter your work email and we'll send the PDF straight to your inbox.

Professional review is required before business use. See our privacy policy.

What's inside

Five pages, zero fluff

Every figure in this guide traces to a named source — FDA and verified 2026 publications.

The mandatory templates

nIVD and IVD eSTAR v7.1, PreSTAR v3.1 — mandatory for 510(k)s since Oct 2023 and De Novos since Oct 2025, unless exempted.

The completeness checks

'eSTAR Complete' kills the RTA review for completeness — smart auto-fill, integrated forms, and the portal size limits.

The PMA expansion

The Sep 18, 2026 draft guidance would make eSTAR mandatory for five PMA submission types — with a 60-day comment window.

Sources & scope

  • fda.gov, eSTAR Program.
  • insider.thefdagroup.com, Draft Guidance Breakdown: FDA Proposes Making eSTAR Mandatory for Certain PMA Submission Types (Sep 2026).
  • medium.com/@verusip, Understanding FDA eSTAR (Nov 2025).

This guide is market-access intelligence, not regulatory or legal advice. eSTAR versions, guidance, and reviewer practice change — professional review is required before business use.

Market Access Strategy Session

eSTAR on your 2026 roadmap? Start with the full picture.

A Market Access Strategy Session maps your submission route — template selection, completeness readiness, and the PMA expansion.

Professional review is required before business use.